If approved, enfortumab vedotin with KEYTRUDA would be the first combination in China to offer an alternative to chemotherapy
The surgeons were able to remove the entire breast while preserving the nipple through tiny hidden incisions
Combination shows consistent benefit across prespecified post-progression outcomes
Hepatitis B infects over 40 million people in India
To accelerate the development of next-generation radioconjugates to treat cancer
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy
The validations confirm the completion of the applications and commence the scientific review process
Both the Ministries signed MoU for anaemia control among adolescent girls using Ayurveda interventions
Kilkari programme aims to offer weekly services, timely accessible, accurate and pertinent 72 audio messages through IVRS about reproductive maternal, neonatal and child health care
Indian Pharma Post brings together the views of industry leaders on the Interim Union Budget 2024-25 announcement and its impact on the industry
Subscribe To Our Newsletter & Stay Updated
